Skip to main content
PMC home page
Thorax logoLink to Thorax
. 2002 Feb;57(2):142–145. doi: 10.1136/thorax.57.2.142

Outcome of Burkholderia cepacia colonisation in an adult cystic fibrosis centre

M Ledson 1, M Gallagher 1, M Jackson 1, C Hart 1, M Walshaw 1
PMCID: PMC1746259  PMID: 11828044

Abstract

Background: Colonisation with Burkholderia cepacia is a poor prognostic indicator in subjects with cystic fibrosis (CF), but outcome prediction is impossible since patients are colonised by different strains with differing pathogenicity. The clinical course of a large cohort of CF patients colonised with UK epidemic (ET12) B cepacia was followed for 5 years and compared with that of the remaining patients in the clinic.

Methods: Pulmonary function, nutritional state, and lung pathogen colonisation were recorded for 5 years before December 1997 or death for all 107 patients who had attended the Liverpool adult CF clinic since 1993. For each patient a time line from study entry to date of death or 1997 was constructed. In 1993 potential risk factors including age and sex were subjected to Cox proportional hazards analysis using the end point of mortality as the outcome variable. The analysis was supplemented by time varying covariables that described the change in FEV1, BMI, and colonisation status across time, and the excess risk associated with B cepacia colonisation was calculated. Subsequently, in those patients who died between 1993 and 1997, predictive factors for death were compared within groups using complete 5 year data.

Results: Thirty seven patients had been colonised by epidemic B cepacia and these patients had four times the mortality of the remainder (p<0.01). In 1993 univariate predictors of mortality were age (alive 19.6 (0.64) v dead 23.8 (1.44); p<0.005) and baseline FEV1 (alive 68.6 (2.5)% predicted v dead 43.2 (4.8)%; p<0.001) with a trend for BMI (p=0.07). However, following time varying covariate Cox proportional hazards analysis, only lower FEV1 (hazards ratio 1.1, 95% confidence limits 1.06 to 1.14; p<0.001) and colonisation with B cepacia (hazards ratio 7.92, confidence limits 2.65 to 23.69; p<0.001) were identified as significant factors for death. Surviving B cepacia patients had similar initial lung function to the remaining surviving patients but had an accelerated loss of lung function over the study period (colonised –1.9% predicted per year v non-colonised –0.3% predicted per year; p<0.05). Deceased patients colonised with B cepacia had better spirometric results than the remaining deceased patients 5 years before death (p<0.05) but lost lung function at a greater rate than non-colonised patients (colonised –6.2% predicted per year v non-colonised –1.9% predicted per year; p<0.05).

Conclusions: This study confirms the excess mortality associated with epidemic B cepacia colonisation and shows that those with poor spirometric values are at the greatest risk.

Full Text

The Full Text of this article is available as a PDF (123.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armstrong D. S., Grimwood K., Carlin J. B., Carzino R., Olinsky A., Phelan P. D. Bronchoalveolar lavage or oropharyngeal cultures to identify lower respiratory pathogens in infants with cystic fibrosis. Pediatr Pulmonol. 1996 May;21(5):267–275. doi: 10.1002/(SICI)1099-0496(199605)21:5<267::AID-PPUL1>3.0.CO;2-K. [DOI] [PubMed] [Google Scholar]
  2. Baltimore R. S., Radnay-Baltimore K., von Graevenitz A., Dolan T. F. Occurrence of nonfermentative gram-negative rods other than Pseudomonas aeruginosa in the respiratory tract of children with cystic fibrosis. Helv Paediatr Acta. 1982;37(6):547–554. [PubMed] [Google Scholar]
  3. Colten H. R. Screening for cystic fibrosis; public policy and personal choices. N Engl J Med. 1990 Feb 1;322(5):328–329. doi: 10.1056/NEJM199002013220510. [DOI] [PubMed] [Google Scholar]
  4. Corey M., Allison L., Prober C., Levison H. Sputum bacteriology in patients with cystic fibrosis in a Toronto hospital during 1970-1981. J Infect Dis. 1984 Feb;149(2):283–283. doi: 10.1093/infdis/149.2.283. [DOI] [PubMed] [Google Scholar]
  5. Corey M., Farewell V. Determinants of mortality from cystic fibrosis in Canada, 1970-1989. Am J Epidemiol. 1996 May 15;143(10):1007–1017. doi: 10.1093/oxfordjournals.aje.a008664. [DOI] [PubMed] [Google Scholar]
  6. Corey M., Levison H., Crozier D. Five- to seven-year course of pulmonary function in cystic fibrosis. Am Rev Respir Dis. 1976 Dec;114(6):1085–1092. doi: 10.1164/arrd.1976.114.6.1085. [DOI] [PubMed] [Google Scholar]
  7. Ederer G. M., Matsen J. M. Colonization and infection with Pseudomonas cepacia. J Infect Dis. 1972 Jun;125(6):613–618. doi: 10.1093/infdis/125.6.613. [DOI] [PubMed] [Google Scholar]
  8. Elborn J. S., Shale D. J., Britton J. R. Cystic fibrosis: current survival and population estimates to the year 2000. Thorax. 1991 Dec;46(12):881–885. doi: 10.1136/thx.46.12.881. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Govan J. R., Brown P. H., Maddison J., Doherty C. J., Nelson J. W., Dodd M., Greening A. P., Webb A. K. Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis. Lancet. 1993 Jul 3;342(8862):15–19. doi: 10.1016/0140-6736(93)91881-l. [DOI] [PubMed] [Google Scholar]
  10. Govan J. R., Deretic V. Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev. 1996 Sep;60(3):539–574. doi: 10.1128/mr.60.3.539-574.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Govan J. R., Hughes J. E., Vandamme P. Burkholderia cepacia: medical, taxonomic and ecological issues. J Med Microbiol. 1996 Dec;45(6):395–407. doi: 10.1099/00222615-45-6-395. [DOI] [PubMed] [Google Scholar]
  12. Henry R. L., Mellis C. M., Petrovic L. Mucoid Pseudomonas aeruginosa is a marker of poor survival in cystic fibrosis. Pediatr Pulmonol. 1992 Mar;12(3):158–161. doi: 10.1002/ppul.1950120306. [DOI] [PubMed] [Google Scholar]
  13. Isles A., Maclusky I., Corey M., Gold R., Prober C., Fleming P., Levison H. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J Pediatr. 1984 Feb;104(2):206–210. doi: 10.1016/s0022-3476(84)80993-2. [DOI] [PubMed] [Google Scholar]
  14. Jacques I., Derelle J., Weber M., Vidailhet M. Pulmonary evolution of cystic fibrosis patients colonized by Pseudomonas aeruginosa and/or Burkholderia cepacia. Eur J Pediatr. 1998 May;157(5):427–431. doi: 10.1007/s004310050844. [DOI] [PubMed] [Google Scholar]
  15. Ledson M. J., Gallagher M. J., Corkill J. E., Hart C. A., Walshaw M. J. Cross infection between cystic fibrosis patients colonised with Burkholderia cepacia. Thorax. 1998 May;53(5):432–436. doi: 10.1136/thx.53.5.432. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Ledson M. J., Gallagher M. J., Walshaw M. J. Chronic Burkholderia cepacia bronchiectasis in a non-cystic fibrosis individual. Thorax. 1998 May;53(5):430–432. doi: 10.1136/thx.53.5.430. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Lewin L. O., Byard P. J., Davis P. B. Effect of Pseudomonas cepacia colonization on survival and pulmonary function of cystic fibrosis patients. J Clin Epidemiol. 1990;43(2):125–131. doi: 10.1016/0895-4356(90)90175-o. [DOI] [PubMed] [Google Scholar]
  18. LiPuma J. J. Burkholderia cepacia. Management issues and new insights. Clin Chest Med. 1998 Sep;19(3):473-86, vi. doi: 10.1016/s0272-5231(05)70094-0. [DOI] [PubMed] [Google Scholar]
  19. Mahadeva R., Webb K., Westerbeek R. C., Carroll N. R., Dodd M. E., Bilton D., Lomas D. A. Clinical outcome in relation to care in centres specialising in cystic fibrosis: cross sectional study. BMJ. 1998 Jun 13;316(7147):1771–1775. doi: 10.1136/bmj.316.7147.1771. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Matthews J. N., Altman D. G., Campbell M. J., Royston P. Analysis of serial measurements in medical research. BMJ. 1990 Jan 27;300(6719):230–235. doi: 10.1136/bmj.300.6719.230. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Muhdi K., Edenborough F. P., Gumery L., O'Hickey S., Smith E. G., Smith D. L., Stableforth D. E. Outcome for patients colonised with Burkholderia cepacia in a Birmingham adult cystic fibrosis clinic and the end of an epidemic. Thorax. 1996 Apr;51(4):374–377. doi: 10.1136/thx.51.4.374. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Pitt T. L., Kaufmann M. E., Patel P. S., Benge L. C., Gaskin S., Livermore D. M. Type characterisation and antibiotic susceptibility of Burkholderia (Pseudomonas) cepacia isolates from patients with cystic fibrosis in the United Kingdom and the Republic of Ireland. J Med Microbiol. 1996 Mar;44(3):203–210. doi: 10.1099/00222615-44-3-203. [DOI] [PubMed] [Google Scholar]
  23. Revets H., Vandamme P., Van Zeebroeck A., De Boeck K., Struelens M. J., Verhaegen J., Ursi J. P., Verschraegen G., Franckx H., Malfroot A. Burkholderia (Pseudomonas) cepacia and cystic fibrosis: the epidemiology in Belgium. Acta Clin Belg. 1996;51(4):222–230. doi: 10.1080/22953337.1996.11718514. [DOI] [PubMed] [Google Scholar]
  24. Rosenfeld M., Davis R., FitzSimmons S., Pepe M., Ramsey B. Gender gap in cystic fibrosis mortality. Am J Epidemiol. 1997 May 1;145(9):794–803. doi: 10.1093/oxfordjournals.aje.a009172. [DOI] [PubMed] [Google Scholar]
  25. Shale D. J. Predicting survival in cystic fibrosis. Thorax. 1997 Apr;52(4):309–309. doi: 10.1136/thx.52.4.309. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Steinkamp G., von der Hardt H. Improvement of nutritional status and lung function after long-term nocturnal gastrostomy feedings in cystic fibrosis. J Pediatr. 1994 Feb;124(2):244–249. doi: 10.1016/s0022-3476(94)70312-4. [DOI] [PubMed] [Google Scholar]
  27. Szaff M., Høiby N., Flensborg E. W. Frequent antibiotic therapy improves survival of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection. Acta Paediatr Scand. 1983 Sep;72(5):651–657. doi: 10.1111/j.1651-2227.1983.tb09789.x. [DOI] [PubMed] [Google Scholar]
  28. Tablan O. C., Chorba T. L., Schidlow D. V., White J. W., Hardy K. A., Gilligan P. H., Morgan W. M., Carson L. A., Martone W. J., Jason J. M. Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome. J Pediatr. 1985 Sep;107(3):382–387. doi: 10.1016/s0022-3476(85)80511-4. [DOI] [PubMed] [Google Scholar]
  29. Taylor R. F., Gaya H., Hodson M. E. Pseudomonas cepacia: pulmonary infection in patients with cystic fibrosis. Respir Med. 1993 Apr;87(3):187–192. doi: 10.1016/0954-6111(93)90090-m. [DOI] [PubMed] [Google Scholar]
  30. Thomassen M. J., Demko C. A., Klinger J. D., Stern R. C. Pseudomonas cepacia colonization among patients with cystic fibrosis. A new opportunist. Am Rev Respir Dis. 1985 May;131(5):791–796. doi: 10.1164/arrd.1985.131.5.791. [DOI] [PubMed] [Google Scholar]
  31. Webb A. K., Egan J. Should patients with cystic fibrosis infected with Burkholderia cepacia undergo lung transplantation? Thorax. 1997 Aug;52(8):671–673. doi: 10.1136/thx.52.8.671. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Whiteford M. L., Wilkinson J. D., McColl J. H., Conlon F. M., Michie J. R., Evans T. J., Paton J. Y. Outcome of Burkholderia (Pseudomonas) cepacia colonisation in children with cystic fibrosis following a hospital outbreak. Thorax. 1995 Nov;50(11):1194–1198. doi: 10.1136/thx.50.11.1194. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Winnie G. B., Cowan R. G. Respiratory tract colonization with Pseudomonas aeruginosa in cystic fibrosis: correlations between anti-Pseudomonas aeruginosa antibody levels and pulmonary function. Pediatr Pulmonol. 1991;10(2):92–100. doi: 10.1002/ppul.1950100210. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES